Paul Alexander - Sonic Healthcare Company Secretary
| SKHCF Stock | USD 16.33 0.24 1.45% |
Executive
Mr. Paul J. Alexander is an Deputy Chief Financial Officer, Company Secretary of Sonic Healthcare Limited. Mr Alexander was the Deputy Chief Financial Officer of Sonic Healthcare Limited since 1997 and Sonics Company Secretary since 2001. Prior to joining Sonic, Mr Alexander gained 10 years experience in professional accounting practice, mainly with Price Waterhouse, and was also Financial Controller and Company Secretary of a subsidiary of a UKheadquartered multinational company for two years. since 2013.
| Tenure | 11 years |
| Phone | 61 2 9855 5444 |
| Web | https://www.sonichealthcare.com |
Sonic Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.1111 % which means that it generated a profit of $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2175 %, meaning that it generated $0.2175 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Lisa MetznerRosas | Neuronetics | N/A | |
| Rick Grubbs | Neuronetics | N/A | |
| Kamal Obbad | ProPhase Labs | N/A | |
| Monica Brady | ProPhase Labs | 47 | |
| Rusty Page | Neuronetics | N/A | |
| Daniel Guthrie | Neuronetics | 41 | |
| Hannah Bible | Star Equity Holdings | 44 | |
| CCP CEBS | Star Equity Holdings | N/A | |
| Ori Karev | Precipio | N/A | |
| Jeffrey Eberwein | Star Equity Holdings | 54 | |
| Mark Demitrack | Neuronetics | N/A | |
| Jessica Olbricht | BiodesixInc | N/A | |
| Mark DeBlock | BiodesixInc | N/A | |
| William Bauta | bioAffinity Technologies Warran | N/A | |
| James MD | BiodesixInc | N/A | |
| Robbie Lunt | BiodesixInc | N/A | |
| Mark Klausner | Neuronetics | N/A | |
| Dallas Coleman | bioAffinity Technologies Warran | N/A | |
| Sergio Miralles | ProPhase Labs | N/A | |
| Jed Latkin | ProPhase Labs | 50 | |
| Robert Morse | ProPhase Labs | 49 | |
Management Performance
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 |
Sonic Healthcare Leadership Team
Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julian Adler, Chief Imaging | ||
| Mrs Schottdorf, Chief Group | ||
| Neville Mitchell, Non-Executive Independent Director | ||
| BEc CA, Deputy Sec | ||
| Louis Panaccio, Non-Executive Independent Director | ||
| Colin Goldschmidt, CEO, Managing Director, Investor Relations Contact Officer, Executive Director | ||
| Peter Savage, Chief Officer | ||
| Elizabeth Wilson, Independent Non-Executive Director | ||
| Philip Dubois, Executive Director | ||
| Kathryn Spargo, Non-Executive Independent Director | ||
| Stephen Fairy, Global Officer | ||
| Christopher Wilks, Finance Director, Executive Director | ||
| FAICD FRCPA, MD CEO | ||
| BCom FACID, CFO Director | ||
| David Byrne, Chief Laboratory | ||
| Prashan Kulasekera, Assistant Sec | ||
| Mark Compton, Non-Executive Independent Director | ||
| Paul Alexander, Company Secretary |
Sonic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 11.17 B | |||
| Shares Outstanding | 480.98 M | |||
| Shares Owned By Insiders | 5.09 % | |||
| Shares Owned By Institutions | 38.62 % | |||
| Price To Earning | 13.88 X | |||
| Price To Book | 1.98 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sonic Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sonic Healthcare's short interest history, or implied volatility extrapolated from Sonic Healthcare options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonic Healthcare Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Sonic Healthcare information on this page should be used as a complementary analysis to other Sonic Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Sonic Pink Sheet analysis
When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |